Lantern Pharma develops cancer drugs using an artificial intelligence platform to match them with suitable patients. It last closed at $0.24 on Nov 20, down 13.70% on the day. The next earnings report for LTRN is expected around Mon, Mar 29, 2027, after the close. For the quarter ended Sep 2026, LTRN reported EPS of -$0.37. Over its last 8 reports the stock moved an average of 5.0% the session after earnings. Over the last 12 months LTRN insiders bought $200K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is LTRN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold LTRN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on LTRNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
Technical AnalysisPrices may be delayed
LTRN · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 112% below its 20 day and 242% below its 50 day average. It is 820% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 19), oversold. The nearest support is the 52 week low at $0.23, and the nearest resistance the Pivot at $0.25.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 35.7%/day
Key levels
$4.3452 week high+1708.3%
$2.25200 day average+837.5%
$1.73100 day average+620.8%
$0.8450 day average+250.0%
$0.68Swing high (Nov 10)+183.3%
$0.5220 day average+116.7%
$0.28Pivot R1+16.7%
$0.25Pivot+4.2%
$0.24Last close
$0.2352 week low−4.2%
$0.22Pivot S1−8.3%
Indicators
RSI (14)
19.41
Oversold below 30
Oversold
MACD
-0.16
Below its signal line
Bearish
Stochastic
2.1
Near the bottom of its range
Oversold
ADX (14)
51.0
Strong downtrend
Williams %R
-96.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-160.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−56.9%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 35.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 170.9%/day
Key levels
$4.3452 week high+1708.3%
$2.25200 day average+837.5%
$1.73100 day average+620.8%
$0.8450 day average+250.0%
$0.68Swing high (Nov 10)+183.3%
$0.5220 day average+116.7%
$0.28Pivot R1+16.7%
$0.25Pivot+4.2%
$0.24Last close
$0.2352 week low−4.2%
$0.22Pivot S1−8.3%
Indicators
RSI (14)
22.00
Oversold below 30
Oversold
MACD
-0.68
Below its signal line
Bearish
Stochastic
1.3
Near the bottom of its range
Oversold
ADX (14)
37.7
Trending down
Williams %R
-99.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-105.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−85.7%
Change over 10 sessions
Bearish
ATR (14)
$0.42
Typical daily range, 170.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for LTRN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how LTRN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow LTRN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for LTRNHow many large options trades hit LTRN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in LTRN in the last 90 days.
From SEC Form 4 filings by LTRN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LTRN is in one of them and how their past LTRN trades turned out.
Lantern Pharma is a Dallas, Texas company that develops cancer drugs. It uses an artificial intelligence platform, called RADR, to analyze large sets of medical and research data and to identify the patients most likely to respond to each drug. Its pipeline includes several small molecule candidates in clinical trials for solid tumors and blood cancers, and it also works on reviving older compounds that were previously halted. The company plans to offer some of its AI tools to other researchers and drug developers.